KeyInvest Weekly Hits

Friday, 15.02.2019

  • Topic 1: European Insurers - A good start into the reporting season
  • Topic 2: Spotify and Twitter - Two platforms with tremendous reach

European Insurers
A good start into the reporting season

The insurance industry has now entered the latest financial reporting season too. Zurich Insurance was the first Swiss insurance company to release its figures for the last fiscal year, while in Germany Munich Re was the frontrunner. Both companies presented squeaky clean balance sheets and exceeded analysts› expectations, and their strong operating profits are reflected in the share prices. The pair is ahead of the market average for the year, and Munich Re shares have just reached an all-time high, while Zurich shares are within sight of the mark.¹ The ETT tracker certificate (symbol: ETINS) for the STOXX™ Europe 600 Insurance Index allows full participation in the growth of the industry with broad diversification.² The Kick-In GOAL (Symbol: KCNGDU) on Zurich Insurance gives conservative investors an opportunity to take a position in the market. A 9.4 percent return is possible with this structured product even if prices move sideways.

Zurich Insurance recorded impressive full-year results with a net profit of USD 3.72 billion that exceeded the highest analyst estimate of USD 3.56 billion. The reported operating profit of 4.57 billion US dollars was also significantly above the consensus estimate. «We have further increased profitability and lowered costs,» said Zurich Chief Executive Mario Greco, commenting on the company’s good numbers. (Source: Zurich Insurance press release of February 2, 2019) Zurich’s goals remain unchanged, as the Group is striving for an after-tax operating profit for the years 2017 – 2019 representing more than twelve percent return on capital. For last year, this figure was 12.1 percent. And shareholders should profit from this success, as for 2018 the Executive Board has proposed a dividend of 19 Swiss francs per share, which is one franc higher than last year.

Munich Re is increasing its dividend as well after announcing good results: For 2018 the world’s largest reinsurer recorded a net profit of approximately 2.3 billion euros, coming after a mere 0.4 billion euros for the previous year. Shareholders can look forward to a 7.5 percent dividend increase, up to 9.25 euros per share.
Over the next few weeks we will find out how many other European insurers will be able to keep pace with Zurich Insurance and Munich Re. Swiss Re and AXA, for example, will be releasing their books on February 21, followed by Swiss Life on February 26 and Baloise on March 7. The greatest anticipation swirls around Allianz: Europe’s largest insurance group will be releasing its figures on February 15. According to Thomson Reuters, analysts are expecting a 15.9 percent rise in earnings per share to 17.65 euros. The German insurance industry can expect 2019 to be a good year overall, the German Insurance Association GDV is projecting premiums to further increase by roughly two percent.

Opportunities: The ETT tracker certificate on the STOXX™ Europe 600 Insurance Index (symbol: ETINS) affords investors a diversified investment opportunity in the industry. This product has no annual management fee, thus tracking the performance of the underlying index exactly.² The index is comprised of 35 stocks; the dividend yield is 4.3 percent. Distributions are accounted on a net basis. The Callable Worst of Kick-In GOAL (symbol: KCNGDU) on Zurich Insurance is a partially protected vehicle for investment in the insurance industry. The product features a risk buffer of 27.4 percent and a sideways yield of 9.4 percent.

Risks: The products are not capital-protected investments. Negative performance of the underlying stock results in corresponding loss in value for the ETT. In contrast, Worst of Kick-In GOALs do offer contingent capital protection. If the underlying is quoted at or below the kick-in level (barrier) once during the product term and the callable function is not triggered, the underlying has to at least trade back at the strike level by the expiration date. If not, payout takes place in the form of delivery of a fixed number of shares. In addition, the investor bears issuer risk with structured products, which means capital invested may be lost if UBS AG should go bankrupt, regardless of the performance of the underlying.

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

STOXX™ Europe 600 Insurance Index (5 years)

The uptrend that lasted from 2016 to 2018 gave way to sideway trading in the 600 point range. The sector index’s bottom-line performance has been good over a five-year period.

Source: UBS AG, Bloomberg

As of 13.02.2019

Zurich Insurance vs. SMI™
(five years, for illustrative purposes only, figures in %)¹

Zurich Insurance shares have traded up and down in recent years. The stock has been slightly more volatile than the overall market, but has ultimately performed the SMI™.

Source: UBS AG, Bloomberg

As of: 13.02.2019

¹) Please be aware that past performance does not indicate future results.
²) The conditions of ETTs are reviewed on a yearly basis and can be adjusted with a deadline of 13 months after the announcement.

ETT on STOXX™ Europe 600 Insurance Index

Symbol ETINS
SVSP Name Tracker Certificates
SPVSP Code 1300
Underlying STOXX™ Europe 600 Insurance Net Return Index
Currency EUR
Ratio 1:1
Administration fee 0.00% p.a.²
Expiry Open End
Participation 100%
Issuer UBS AG, London
Bid/Ask EUR 600.50 / 604.00
 

5.00% p.a. Callable Kick-In GOAL on Zurich Insurance

Symbol KCNGDU
SVSP Name Barrier Reverse Convertible
SPVSP Code 1230 (Callable)
Underlying Zurich Insurance
Currency CHF
Coupon 5.00% p.a.
Sideways return 9.38% / 5.55% p.a.
Kick-In Level (Distance) CHF 231.825 (27.55%)
Sideways return 9.38% / 5.55% p.a.
Expiry 05.10.2020
Issuer UBS AG, London
Bid/Ask 97.95% / 98.95%
 

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Source: UBS AG, Bloomberg

As of: 13.02.2019

Market overview

Index Quotation Week¹
SMI™ 9’164.06 0.2%
SLI™ 1’417.38 0.1%
S&P 500™ 2’753.03 0.8%
Euro STOXX 50™ 3’202.37 -0.3%
S&P™ BRIC 40 4’178.84 0.0%
CMCI™ Compos. 905.13 -0.9%
Gold (troy ounce) 1’315.10 USD 0.1%

¹ Change based on the closing price of the previous day compared to the closing price a week ago.

SMI™ vs. VSMI™ 1 year

smi vs vsmi

The VSMI™ Index is calculated since 2005. It shows the volatility of the stocks within the SMI™ index. A portfolio which reacts only to changes in volatility instead of volatility itself is relevant for the calculation. Thereby, the VSMI™ methodology uses the squared volatility, known as variance, of the SMI options with remaining time to expiry of 30 days traded at the Eurex.

Source: UBS AG, Bloomberg

As of: 13.02.2019

Spotify and Twitter
Two platforms with tremendous reach

Whether listening to music on the way to work or popping off a quick tweet in the evening – for many people, Spotify and Twitter are an integral part of everyday life. Together the streaming provider and short message service had more than half a billion active users at the end of 2018. The two make for an interesting Early Redemption (ER) Kick-In GOAL product too (symbol: KCTLDU). This product offers a potential sideways annualized yield of 14.5 percent p.a. Both stocks have declined since their IPOs in November 2018, the current worst-performer of the two, Twitter, still has a safety buffer of more than 40 percent.

Spotify, Twitter and many other internet stocks got off to a strong start to the year¹, but the two lost momentum after releasing their financials. Spotify announced recording an operating profit for the first quarter ever despite analysts expecting the company to remain in the red. Growing at a rate of 30 percent, the music platform managed to roughly meet sales expectations for the period October to December 2018. Investors were apparently concerned about the outlook for this Swedish company, as Spotify is forecasting declining gross margin for 2019 among other things. (Source: Thomson Reuters Media Report, February 6, 2019)

The US short message service Twitter has recently found itself in a similar situation, reporting strong figures for the fourth quarter of 2019, partly on rising video advertising income, which contributed to a 24 percent increase in sales. The social media company reported better-than-expected earnings as well, yet investors were still disappointed about the outlook for Twitter. For the first quarter of 2019 management estimates sales will range between 715 and 775 million US dollars, the mid-point of which is below the average sales previously projected by analysts. (Source: Thomson Reuters Media Report, 2/7/2019)

Opportunities: The ER Kick-In GOAL is an alternative option to directly investing in Spotify and Twitter (symbol: KCTLDU). As long as neither of the stocks falls to or below their respective barrier, the structured product can afford an annualized yield of up to 14.5 percent at maturity. The underlying stocks are currently trading more than 40 percent above the kick-in level. The first possible early redemption is on November 7, 2019. If Spotify and Twitter trade at or above the starting level on this day or any other quarterly observation day, the Kick-in GOAL expires early. In such case, investors will receive the full nominal amount plus pro rata coupon transferred to their account a few days later.

Risks: Kick-In GOALs are not capital-protected investments. If one of the underlyings trades at or below the applicable kick-in level (barrier) during the product term and the early redemption feature cannot apply, the product may be redeemed on the expiry date in cash based on the price of the weaker performing of the two (relative to the strike, not to exceed nominal value plus coupon). Losses are likely in such case. In addition, investors in structured products bear issuer risk, which means capital invested may be lost if UBS AG should go bankrupt, regardless of the performance of the underlying.

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Spotify Technology vs. Twitter
(since Spotify IPO, for illustrative purposes only; figures in %)¹

Source: UBS AG, Bloomberg

As of: 13.02.2019

12.00% p.a. Early Redemption Kick-In GOAL on Spotify Technology / Twitter

Symbol KCTLDU
SVSP Name Barrier Reverse Convertibles
SPVSP Code 1230 (Auto-Callable)
Underlyings Spotify Technology / Twitter
Currency USD
Coupon 12.00% p.a.
Sideways return 16.29% (12.84% p.a.)
Kick-In Level (Distance)
Spotify: USD 72.885 (49.22%)
Twitter: USD 17.495 (43.78%)
Expiry 08.05.2020
Issuer UBS AG, London
Bid/Ask 97.50% / 98.50%
 

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Source: UBS AG, Bloomberg

As of: 13.02.2019

¹) Please be aware that past performance does not indicate future results.
²) The conditions of ETTs are reviewed on a yearly basis and can be adjusted with a deadline of 13 months after the announcement.

This material has been prepared by UBS AG or one of its affiliates («UBS»). This material is for distribution only as permitted by law. It is not prepared for the needs of any specific recipient. It is published solely for information and is not a solicitation or offer to buy or sell any securities or related financial instruments (“Instruments”). UBS makes no representation or warranty, either express or implied, on the completeness or reliability of the information contained in this document (“Information”) except that concerning UBS AG and its affiliates. The Information should not be regarded by recipients as a substitute for using their own judgment. Any opinions expressed in this material may change without notice and may be contrary to opinions expressed by other business areas of UBS as a result of using different assumptions or criteria. UBS is under no obligation to update the Information. UBS, its officers, employees or clients may have or have had an interest in the Instruments and may at any time transact in them. UBS may have or have had a relationship with entities referred to in the Information. Neither UBS nor any of its affiliates, or their officers or employees, accepts any liability for any loss arising from use of the Information. This presentation is not a basis for entering into a transaction. Any transaction between you and UBS will be subject to the detailed provisions of the term sheet, confirmation or electronic matching systems relating to that transaction. Clients wishing to effect transactions should contact their local sales representative.
This information is communicated by UBS AG and/or its affiliates («UBS»). * (see below) UBS may from time to time, as principal or agent, have positions in, or may buy or sell, or make a market in any securities, currencies, financial instruments or other assets underlying the product to which this website relates (the «Structured Product»). UBS may provide investment banking and other services to and/or have officers who serve as directors of the companies referred to in this website. UBS’s trading and/or hedging activities related to the Structured Product may have an impact on the price of the underlying asset and may affect the likelihood that any relevant barrier or relevant trigger event is crossed or triggered. UBS has policies and procedures designed to minimise the risk that officers and employees are influenced by any conflicting interest or duty and that confidential information is improperly disclosed or made available. UBS may pay or receive brokerage or retrocession fees in connection with the Structured Product described herein. In respect of any Structured Product that is a security, UBS may, in certain circumstances, sell the Structured Product to dealers and other financial institutions at a discount to the issue price or rebate to them for their own account some proportion of the issue price. Further information is available on request. Structured Products are complex and may involve a high risk of loss. Prior to purchasing the Structured Product you should consult with your own legal, regulatory, tax, financial and accounting advisors to the extent you consider it necessary, and make your own investment, hedging and trading decisions (including decisions regarding the suitability of the Structured Product) based upon your own judgement and advice from those advisers you consider necessary. Save as otherwise expressly agreed in writing, UBS is not acting as your financial adviser or fiduciary in relation to the Product. UBS generally hedges its exposure to Structured Products, although it may elect not to hedge or to partially hedge any Structured Product. UBS’s hedging activity may be conducted through transactions in the underlying asset, index or instrument or in options, futures or other derivatives related to the underlying asset, index or instrument on publicly traded markets or otherwise, and may have an impact on the price of the under-lying asset. If a transaction is cash settled, UBS will generally unwind or offset any hedge it has for such Structured Product in close proximity to the relevant valuation time or period. In some cases, this activity may affect the value of the Structured Product. Unless stated otherwise in this document, (i) this document is for information purposes only and should not be construed as an offer, personal recommendation or solicitation to purchase the Structured Product and should not be treated as giving investment advice, and (ii) the terms of any investment in the Structured Product will be exclusively subject to the detailed provisions, including risk considerations, contained in the more detailed legal documentation that relates to the Structured Product (being the confirmation, information memorandum, prospectus or other issuer documentation as relevant). UBS makes no representation or warranty relating to any information herein which is derived from independent sources. This document shall not be copied or reproduced without UBS’s prior written permission. In respect of any Structured Product that is a security, no action has been or will be taken in any jurisdiction that would permit a public offering of the Product, save where explicitly stated in the issuer documentation. The Structured Product must be sold in accordance with all applicable selling restrictions in the jurisdictions in which it is sold.
© UBS 2018. All rights reserved. UBS prohibits the forwarding of this information without the approval of UBS.